Coronavirus (COVID-19) ACEi/ARB Investigation
A phase 4 trial registered on ClinicalTrials.gov. The registry status is suspended. It plans to enroll 2414 participants.
Also called NCT04330300
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose prevention
- Phase
- Phase 4
- Enrolled
- 2,414 participants
- Registry
-
NCT04330300
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Ireland
- Registry status
- Suspended
Technical summary
Registry record NCT04330300. Randomized; no masking; primary purpose prevention. Start 2020-04-30 (actual); primary completion 2021-07-31 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Coronavirus (COVID-19) ACEi/ARB Investigation
- Acronym
- CORONACION
- Condition
- Hypertension
- Condition
- COVID-19
- Intervention (Drug)
- Thiazide or Thiazide-like diuretics
- Intervention (Drug)
- Calcium Channel Blockers
- Intervention (Drug)
- ACE inhibitor
- Intervention (Drug)
- Angiotensin receptor blocker
- Lead sponsor
- National University of Ireland, Galway, Ireland
Record details
- Record id
cardio:ct-nct04330300- Content hash
fb8fb1f119c3ebeaae0d603467e42708663e1a0e2d6ac485e36e344662427f79